The divestiture “fortifies our confidence” to reach positive cash flow in 2026, said Amwell CEO Ido Schoenberg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback